Order:
  1. Categorized priority systems: a new tool for fairly allocating scarce medical resources in the face of profound social inequities.Tayfun Sönmez, Parag A. Pathak, M. Utku Ünver, Govind Persad, Robert D. Truog & Douglas B. White - 2021 - Chest 153 (3):1294-1299.
    The coronavirus disease 2019 (COVID-19) pandemic has motivated medical ethicists and several task forces to revisit or issue new guidelines on allocating scarce medical resources. Such guidelines are relevant for the allocation of scarce therapeutics and vaccines and for allocation of ICU beds, ventilators, and other life-sustaining treatments or potentially scarce interventions. Principles underlying these guidelines, like saving the most lives, mitigating disparities, reciprocity to those who assume additional risk (eg, essential workers and clinical trial participants), and equal access may (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  2. Reserve system design for allocation of scarce medical resources in a pandemic: some perspectives from the field.Parag Pathak, Govind Persad, Tayfun Sönmez & M. Utku Unver - 2022 - Oxford Review of Economic Policy 38 (4):924–940.
    Reserve systems are a tool to allocate scarce resources when stakeholders do not have a single objective. This paper introduces some basic concepts about reserve systems for pandemic medical resource allocation. At the onset of the Covid-19 pandemic, we proposed that reserve systems can help practitioners arrive at compromises between competing stakeholders. More than a dozen states and local jurisdictions adopted reserve systems in initial phases of vaccine distribution. We highlight several design issues arising in some of these implementations. We (...)
    Download  
     
    Export citation  
     
    Bookmark  
  3.  63
    A Multicenter Weighted Lottery to Equitably Allocate Scarce COVID-19 Therapeutics.D. B. White, E. K. McCreary, C. H. Chang, M. Schmidhofer, J. R. Bariola, N. N. Jonassaint, Parag A. Pathak, G. Persad, R. D. Truog, T. Sonmez & M. Utku Unver - 2022 - American Journal of Respiratory and Critical Care Medicine 206 (4):503–506.
    Shortages of new therapeutics to treat coronavirus disease (COVID-19) have forced clinicians, public health officials, and health systems to grapple with difficult questions about how to fairly allocate potentially life-saving treatments when there are not enough for all patients in need (1). Shortages have occurred with remdesivir, tocilizumab, monoclonal antibodies, and the oral antiviral Paxlovid (2) -/- Ensuring equitable allocation is especially important in light of the disproportionate burden experienced during the COVID-19 pandemic by disadvantaged groups, including Black, Hispanic/Latino and (...)
    Download  
     
    Export citation  
     
    Bookmark